跳至主要内容
临床试验/DRKS00026926
DRKS00026926招募中不适用

Influence of therapeutic drug monitoring (TDM) on the tolerability and efficacy of 5-FU-containing chemotherapy in patients with colorectal carcinoma in the colorectal center at St.-Franziskus-Hospital Münster: a prospective, monocentric observational study. - 5FU-TDM

St. Franziskus-Hospital GmbH0 个研究点目标入组 50 人开始时间: 2021年10月18日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 95 Years(—)
性别
All

入选标准

  • Patients with stage II and III colon cancer for whom adjuvant chemotherapy is indicated and planned according to the FOLFOX4 regimen.
  • - Patients with stage IV colon cancer in whom palliative or conversion chemotherapy according to the FOLFOX4 +/- bevacizumab regimen is indicated and planned.

排除标准

  • Non-consenting adults,
  • Pregnant and breastfeeding women

研究者

相似试验